BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21102413)

  • 1. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
    Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA
    Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
    Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
    Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
    Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid proliferations in myeloid neoplasms.
    Wang SA; Hasserjian RP
    Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.
    Margolskee E; Mikita G; Rea B; Bagg A; Zuo Z; Sun Y; Goswami M; Wang SA; Oak J; Arber DA; Allen MB; George TI; Rogers HJ; Hsi E; Hasserjian RP; Orazi A
    Mod Pathol; 2018 Jun; 31(6):873-880. PubMed ID: 29403082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
    Chisholm KM; Heerema-McKenney AE; Choi JK; Smith J; Ries RE; Hirsch BA; Raimondi SC; Alonzo TA; Wang YC; Aplenc R; Sung L; Gamis AS; Meshinchi S; Kahwash SB
    Blood Adv; 2020 Dec; 4(23):6000-6008. PubMed ID: 33284945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.
    Wong E; Juneja S
    Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure erythroid leukemia.
    Wang W; Wang SA; Medeiros LJ; Khoury JD
    Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute erythroid leukemia.
    Zuo Z; Polski JM; Kasyan A; Medeiros LJ
    Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukaemia with a pure erythroid phenotype: under-recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome.
    Park DC; Ozkaya N; Lovitch SB
    Histopathology; 2017 Aug; 71(2):316-321. PubMed ID: 28261852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    Hasserjian RP; Zuo Z; Garcia C; Tang G; Kasyan A; Luthra R; Abruzzo LV; Kantarjian HM; Medeiros LJ; Wang SA
    Blood; 2010 Mar; 115(10):1985-92. PubMed ID: 20040759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.
    Wong E; Ling V; Westerman D; Morgan S; Juneja S
    J Clin Pathol; 2015 Apr; 68(4):301-5. PubMed ID: 25609576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.
    Ko PS; Liu YC; Yeh CM; Gau JP; Yu YB; Hsiao LT; Tzeng CH; Chen PM; Chiou TJ; Liu CJ; Liu JH
    PLoS One; 2017; 12(2):e0172029. PubMed ID: 28196090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity.
    Reinig EF; Greipp PT; Chiu A; Howard MT; Reichard KK
    Mod Pathol; 2018 May; 31(5):705-717. PubMed ID: 29327715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
    Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
    BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance.
    Pourabdollah M; Chang H
    Blood; 2017 Feb; 129(7):918. PubMed ID: 28209754
    [No Abstract]   [Full Text] [Related]  

  • 19. To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Di Genua C; Nerlov C
    Exp Hematol; 2021 May; 97():6-13. PubMed ID: 33600869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
    Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.